Pim Pharmaceuticals is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Jawa Timur. The company was founded in 1920. Pim Pharmaceuticals, a venerable name in the pharmaceutical industry, was established by visionary founders who sought to address the healthcare needs of the region. Over the decades, the company has expanded its operations, focusing on both primary and secondary business lines, including the development and manufacturing of generic and branded medications. The company boasts a robust local presence with multiple branches across Indonesia, ensuring widespread distribution and accessibility of its products. Pim Pharmaceuticals is renowned for its diverse range of pharmaceutical products, including antibiotics, pain relievers, and cardiovascular medications, marketed under well-recognized brand names. Internationally, Pim Pharmaceuticals has extended its footprint to several countries in Southeast Asia, exporting its high-quality products to meet global demand. The company has established strategic partnerships with international pharmaceutical firms to enhance its research and development capabilities and to co-develop innovative healthcare solutions. Pim Pharmaceuticals is an active member of various pharmaceutical associations, contributing to industry standards and practices. The company is committed to sustainable practices and ethical operations, aligning with global health and safety regulations. With a vision to improve global health outcomes, Pim Pharmaceuticals is dedicated to innovation and excellence in pharmaceutical care. The company's mission is to provide affordable and effective healthcare solutions, ensuring a healthier future for communities worldwide.
Headquarters
Kav 21 - Kahuripan Nirwana
Sidoarjo; East Java;
Postal Code: 61228
Contact Details: Purchase the PT Pim Pharmaceuticals report to view the information.
Website: http://www.pimpharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service